Healthy Skepticism Library item: 10567

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Kondro W.
US proposes more stringent conflict-of-interest rules.
CMAJ 2007 May 22; 176:(11):1571-2
http://www.cmaj.ca/cgi/content/full/176/11/1571

Abstract:

The US Food and Drug Administration (FDA) has moved to stave-off a political firestorm by proposing new conflict of interest rules that would limit the ability of medical experts with financial interests in pharmaceutical companies to sit on the agency’s influential scientific advisory committees.

The proposed rules would prohibit physicians or scientists (and, by extension, their immediate families and employers) who have over $50000 in financial ties to a company over the previous 12 months from participating on a panel reviewing one of that company’s products. Medical experts who have received less than $50000 in the previous year could participate in the discussion but would not be allowed to vote…

Keywords:
Publication Types: News MeSH Terms: Advisory Committees/legislation & jurisprudence* Canada Conflict of Interest/legislation & jurisprudence* Drug Industry/legislation & jurisprudence* Humans Research Support/ethics United States United States Food and Drug Administration

Notes:

Free full text